Back

Microvesicles derived from hypoxic human mesenchymal stem cells improve prevent arrhythmia via miRNA 26 in ischemia-reperfusion model.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Cardiac regeneration and repair Stem cells and cell therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Hyewon Park

Severance Hospital, Seoul (Korea (Republic of))

34 More presentations in this session

Presentation thumbnail
Granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up- FINAL RESULTS
Associate Professor D. D'Amario (Novara, IT)
Abstract
Presentation thumbnail
Cardiac bone marrow-derived cell-based therapy associated with scaffold for heart regeneration
Miss I. Borrego (Fribourg, CH)
Abstract
Presentation thumbnail
Cardiac progenitor cells with resveratrol delivered into mitochondria can ameliorate survival of doxorubicin-induced cardiomyopathy mouse via mitochondrial activation of damaged myocardium.
Doctor J. Abe (Sapporo, JP)
Abstract
Presentation thumbnail
Investigating the link between cardiac progenitors differentiation and the shift from glycolysis to oxidative metabolism
Miss E. Andre (Brussels, BE)
Abstract
Presentation thumbnail
Homing of endogenous bone marrow mesenchymal stem cells to rat infarcted myocardium via ultrasound-mediated recombinant SDF-1a adenovirus in microbubbles
Doctor Y. Mu (Urumqi, CN)

Access the full session

Session thumbnail
Poster session 3 - Cardiac regeneration and repair

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources